Companies Cardinal Health
Cardinal Health (CAH): executive pay, fiscal 2026
Free brief. Every figure links to the company’s own filing.
Velarion Intel: free for 3 days, no card →Email me Cardinal Health’s executive pay brief as a PDF
You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO vs. named peers50th pct.Of 22 peer CEOs
CEO pay, last three years
- $25,650,709FY2024
- $18,976,195FY2025
- $22,574,349FY2026
CEO total pay was $22,574,349 in fiscal 2026, up from $18,976,195 in fiscal 2025.
FY2026: salary $1,500,000 · bonus $0 · stock awards $16,259,918 · option awards $0
Executives and directors
Aaron Alt · CFODeborah Weitzman · ExecutiveJason Hollar · CEOJessica Mayer · General CounselStephen Mason · ExecutiveAkhil Johri · Independent DirectorChristine A. Mundkur · Independent DirectorDavid C. Evans · Independent DirectorGregory B. Kenny · Former director (through FY2026)Michelle M. Brennan · Independent DirectorNancy Killefer · Independent DirectorPatricia A. Hemingway Hall · Chair of the BoardRobert W. Azelby · Independent DirectorRobert W. Musslewhite · Independent DirectorSheri H. Edison · Independent DirectorSudhakar Ramakrishna · Independent Director
Frequently asked questions
Who was the highest-paid executive at Cardinal Health in fiscal 2026?
As disclosed, Jason Hollar (Chief Executive Officer) was the highest-paid executive at Cardinal Health in fiscal 2026, with total compensation of $22,574,349.
How does Cardinal Health's chief executive pay compare to its disclosed peer group?
As disclosed, Jason Hollar's total compensation ranked at the 50th percentile of Cardinal Health's disclosed peer group.
What is Cardinal Health's CEO-to-median employee pay ratio?
As disclosed, Cardinal Health's CEO-to-median employee pay ratio was 288:1.
How did shareholders vote on Cardinal Health's executive compensation?
As disclosed, 90.7% of shareholders supported Cardinal Health's executive compensation in the latest say-on-pay vote.
How much does Cardinal Health spend in total on board compensation for fiscal 2026?
As disclosed, Cardinal Health reported total board compensation of $4,226,229 for fiscal 2026.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Jason Hollar | $1,500,000 | $0 | $16,259,918 | $0 | $4,278,750 | $0 | $535,681 | $22,574,349 |
| Chief Executive Officer | ||||||||
| Aaron Alt | 896,233 | 0 | 4,318,999 | 0 | 1,606,945 | 0 | 37,996 | 6,860,173 |
| Chief Financial Officer | ||||||||
| Deborah Weitzman | 770,479 | 0 | 4,064,943 | 0 | 1,254,340 | 0 | 30,395 | 6,120,157 |
| Chief Executive Officer, Pharmaceutical and Specialty Solutions Segment | ||||||||
| Jessica Mayer | 741,233 | 0 | 3,556,822 | 0 | 1,208,210 | 0 | 27,918 | 5,534,183 |
| Chief Legal and Compliance Officer | ||||||||
| Stephen Mason | 761,986 | 0 | 3,404,479 | 0 | 1,112,500 | 0 | 14,400 | 5,293,365 |
| Chief Executive Officer, Global Medical Products and Distribution Segment | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2026 total | FY2025 total | FY2024 total | Δ FY2025→2026 |
|---|---|---|---|---|
| Jason Hollar | $22,574,349 | $18,976,195 | $25,650,709 | ↑ +3,598,154 |
| Aaron Alt | 6,860,173 | 6,210,035 | 6,842,001 | ↑ +650,138 |
| Deborah Weitzman | 6,120,157 | 5,507,857 | 5,085,987 | ↑ +612,300 |
| Jessica Mayer | 5,534,183 | 4,925,352 | 4,657,765 | ↑ +608,831 |
| Stephen Mason | 5,293,365 | 4,745,044 | 7,335,463 | ↑ +548,321 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
Our executive compensation program is designed to support our long-term growth, with accountability for key annual results. It emphasizes performance and retention using long-term, stock-based incentive compensation to align executive interests with shareholders, while maintaining a competitive program to attract and retain critical talent.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Korn Ferry |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | true |
Equity grants and outstanding awards
No plan-based awards are on file for this fiscal year.
Outstanding equity awards at fiscal year-end 2026
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Stephen Mason | RSU | 20,819 | — | $4,945,762 |
| Jessica Mayer | RSU | 20,873 | — | 4,958,590 |
| Deborah Weitzman | RSU | 24,132 | — | 5,732,798 |
| Aaron Alt | RSU | 26,408 | — | 6,273,484 |
| Jason Hollar | RSU | 92,603 | — | 21,998,769 |
| Jessica Mayer | PSU | 109,538 | — | 26,021,847 |
| Stephen Mason | PSU | 110,004 | — | 26,132,550 |
| Deborah Weitzman | PSU | 127,497 | — | 30,288,187 |
| Aaron Alt | PSU | 135,640 | — | 32,222,638 |
| Jason Hollar | PSU | 460,863 | — | 109,482,614 |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Gregory B. KennyIndependent · Not standing for re-election · Departed during FY | $178,000 | $334,937 | — | — | $20,000 | $532,937 |
| Patricia A. Hemingway HallIndependent · Board Chair · Governance and Sustainability | 162,686 | 289,158 | — | — | 20,000 | 471,844 |
| Nancy KilleferIndependent · Governance and Sustainability · Human Resources and Compensation | 146,277 | 209,975 | — | — | 20,000 | 376,252 |
| Sheri H. EdisonIndependent · Governance and Sustainability · Risk Oversight (Chair) | 146,277 | 209,975 | — | — | 20,000 | 376,252 |
| David C. EvansIndependent · Audit (Chair) · Human Resources and Compensation | 146,114 | 209,975 | — | — | 10,000 | 366,089 |
| Akhil JohriIndependent · Audit · Governance and Sustainability | 128,302 | 209,975 | — | — | 20,000 | 358,277 |
| Robert W. MusslewhiteIndependent · Human Resources and Compensation (Chair) · Risk Oversight | 123,139 | 209,975 | — | — | 20,000 | 353,114 |
| Robert W. AzelbyIndependent · Audit · Human Resources and Compensation | 123,139 | 209,975 | — | — | 20,000 | 353,114 |
| Sudhakar RamakrishnaIndependent · Audit · Risk Oversight | 123,139 | 209,975 | — | — | 20,000 | 353,114 |
| Michelle M. BrennanIndependent · Governance and Sustainability (Chair) · Human Resources and Compensation | 142,147 | 209,975 | — | — | 0 | 352,122 |
| Christine A. MundkurIndependent · Audit · Risk Oversight | 123,139 | 209,975 | — | — | 0 | 333,114 |
| Jason M. HollarEmployee director | — | — | — | — | — | 0 |
Board fee structure and ownership guideline
| Annual cash retainer | $125,000 |
|---|---|
| Annual equity retainer | $210,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 30,000 / 25,000 / 25,000 |
| Stock ownership guideline | $5 |
Total cost of the board
| Component | FY2026 |
|---|---|
| Cash retainers and fees | $1,542,359 |
| Equity awards (grant-date value) | $2,513,870 |
| All other compensation | $170,000 |
| Total cost of the board | $4,226,229 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names Cardinal Health as a peer
Companies that benchmark against CAH
13 companies name CAH as a compensation peer
- Archer-Daniels-Midland CoADMFY2025
- Cencora, Inc.CORFY2025
- CENTENE CORPCNCFY2025
- Cigna GroupCIFY2025
- CVS HEALTH CorpCVSFY2025
- HCA Healthcare, Inc.HCAFY2025
- HENRY SCHEIN INCHSICFY2025
- HUMANA INCHUMFY2025
- Ingram Micro Holding CorpINGMFY2025
- MCKESSON CORPMCKFY2026
- TD SYNNEX CORPSNXFY2025
- UNITEDHEALTH GROUP INCUNHFY2025
Each company listed discloses CAH in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named CAH in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
Disclosed peer group — fiscal year 2026
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
COR Cencora, Inc.WBA Walgreens Boots Alliance, Inc.UPS United Parcel Service, Inc.ELV Elevance Health, Inc.BAX Baxter International Inc.MCK McKesson CorporationCI The Cigna GroupCVS CVS Health CorporationFDX FedEx CorporationLH Labcorp Holdings Inc.TMO Thermo Fisher Scientific Inc.UNH UnitedHealth Group IncorporatedHSIC Henry Schein, Inc.JNJ Johnson & JohnsonTGT Target CorporationSYK Stryker CorporationBSX Boston Scientific CorporationDHR Danaher CorporationSYY Sysco CorporationKR The Kroger Co.BDX Becton, Dickinson and CompanyACH Accendra Health, Inc.
Peer reciprocity
Of the companies Cardinal Health names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
✓ Cencora, Inc. (COR)47— Walgreens Boots Alliance, Inc. (WBA)48— United Parcel Service, Inc. (UPS)49✓ Elevance Health, Inc. (ELV)50— Baxter International Inc. (BAX)51 McKesson Corporation (MCK)✓ The Cigna Group (CI)52 CVS Health Corporation (CVS) FedEx Corporation (FDX)— Labcorp Holdings Inc. (LH)53 Thermo Fisher Scientific Inc. (TMO)✓ UnitedHealth Group Incorporated (UNH)54✓ Henry Schein, Inc. (HSIC)55— Johnson & Johnson (JNJ)56— Target Corporation (TGT)57— Stryker Corporation (SYK)58— Boston Scientific Corporation (BSX)59— Danaher Corporation (DHR)60— Sysco Corporation (SYY)61 The Kroger Co. (KR)— Becton, Dickinson and Company (BDX)62— Accendra Health, Inc. (ACH)63
Reciprocity shown where the peer’s own current proxy has been read — each mark is cited in the register to that peer’s filing. A dash means the peer’s current proxy was read and names no reciprocal group including Cardinal Health.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific Inc. | 2025 | Marc Casper | $1,785,534 | $65,730,211 | $7,951,377 | $3,742,123 | $79,923,350 |
| 2 | UnitedHealth Group Incorporated | 2025 | Stephen Hemsley | 596,154 | 0 | 60,000,024 | 0 | 60,938,062 |
| 3 | Johnson & Johnson | 2025 | Joaquin Duato | 1,600,000 | 15,028,948 | 5,927,995 | 4,298,700 | 32,758,111 |
| 4 | Baxter International Inc. | 2025 | Andrew Hider | 499,315 | 23,133,518 | 3,185,053 | 820,125 | 29,805,182 |
| 5 | FedEx Corporation | 2026 | Rajesh Subramaniam | 1,550,000 | 6,731,364 | 3,715,062 | 10,593,500 | 27,554,018 |
| 6 | McKesson Corporation | 2026 | Brian Tyler | 1,591,667 | 17,201,202 | 0 | 4,456,668 | 24,213,044 |
| 7 | Danaher Corporation | 2025 | Rainer Blair | 1,400,000 | 9,292,370 | 8,386,657 | 4,194,400 | 23,795,280 |
| 8 | Boston Scientific Corporation | 2025 | Michael Mahoney | 1,442,603 | 13,608,056 | 3,749,980 | 4,002,001 | 23,532,050 |
| 9 | United Parcel Service, Inc. | 2025 | Carol Tomé | 1,509,713 | 17,550,546 | 1,358,754 | 2,264,569 | 22,878,788 |
| 10 | The Cigna Group | 2025 | David Cordani | 1,600,000 | 13,929,161 | 3,400,019 | 3,200,000 | 22,866,134 |
| 11 | Elevance Health, Inc. | 2025 | Gail Boudreaux | 1,600,000 | 13,440,277 | 4,199,765 | 2,768,000 | 22,582,314 |
| 12 | Cardinal Health | 2026 | Jason Hollar | 1,500,000 | 16,259,918 | 0 | 4,278,750 | 22,574,349 |
| 13 | Stryker Corporation | 2025 | Kevin Lobo | 1,500,000 | 9,764,136 | 6,920,781 | 2,250,000 | 21,401,495 |
| 14 | CVS Health Corporation | 2025 | J. David Joyner | 1,500,000 | 14,499,931 | 0 | 4,695,900 | 21,214,084 |
| 15 | Labcorp Holdings Inc. | 2025 | Adam Schechter | 1,435,000 | 11,400,463 | 2,754,582 | 2,062,095 | 18,339,913 |
| 16 | Cencora, Inc. | 2025 | Robert Mauch | 1,350,000 | 12,000,218 | 0 | 4,283,213 | 18,256,227 |
| 17 | Sysco Corporation | 2026 | Kevin Hourican | 1,435,538 | 10,391,759 | 2,579,986 | 2,905,602 | 17,899,369 |
| 18 | Becton, Dickinson and Company | 2025 | Thomas Polen | 1,395,463 | 9,991,854 | 3,311,861 | 1,852,010 | 17,129,140 |
| 19 | The Kroger Co. | 2025 | Ronald L. Sargent | 3,975,806 | 10,000,077 | — | — | 14,037,608 |
| 20 | Walgreens Boots Alliance, Inc. | 2024 | Timothy Wentworth | 1,290,385 | 11,600,744 | 0 | 0 | 13,282,800 |
| 21 | Henry Schein, Inc. | 2025 | Stanley Bergman | 1,707,000 | 7,764,800 | 0 | 2,289,251 | 12,013,915 |
| 22 | Accendra Health, Inc. | 2025 | Edward Pesicka | 1,150,000 | 9,560,140 | — | 345,000 | 11,157,809 |
| 23 | Target Corporation | 2025 | Michael Fiddelke | 1,065,385 | 7,853,253 | 0 | 300,882 | 9,598,071 |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Incentive design against the same peers
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Cardinal Health | not disclosed | PSU 60 · RSU 40 | Yes — Relative TSR modifier | Korn Ferry |
| Accendra Health, Inc. | 20% | RSU 50 · PSU 50 | not disclosed | Frederic W. Cook & Co., Inc. (FW Cook) |
| Baxter International Inc. | not disclosed | PSU 50 · RSU 25 · Option 25 | No | Aon |
| Becton, Dickinson and Company | 85% | PSU 50 · Options 25 · RSU 25 | No | Semler Brossy |
| Boston Scientific Corporation | 173% | PSU 50 · RSU 25 · Options 25 | No | Semler Brossy Consulting Group, LLC |
| Cencora, Inc. | 181.3% | PSU 60 · RSU 40 | Yes — Relative TSR | Pearl Meyer & Partners |
| CVS Health Corporation | 156.5% | PSU 60 · RSU 20 · Options 20 | Yes — rTSR Modifier | Korn Ferry |
| Danaher Corporation | not disclosed | Options 50 · RSU 50 | Yes — Relative TSR | FW Cook |
| Elevance Health, Inc. | 86.5% | PSU 52 · RSU 24 · Options 24 | No | Willis Towers Watson (WTW) |
| FedEx Corporation | 112.5% | not disclosed | Yes — Relative TSR (FY24-FY26 LTI Cash Plan) | Meridian Compensation Partners, LLC |
| Henry Schein, Inc. | 89.3% | PSU 65 · RSU 35 | No | Pearl Meyer |
| Johnson & Johnson | not disclosed | not disclosed | Yes — Relative TSR | Semler Brossy Consulting Group |
| Labcorp Holdings Inc. | 95.8% | PSU 60 · RSU 20 · Options 20 | Yes — RELATIVE TSR MODIFIER | FW Cook |
| McKesson Corporation | 140% | PSU 60 · RSU 40 | Yes — Total Shareholder Return (TSR) relative to comparator group | Korn Ferry |
| Stryker Corporation | 100% | PSU 48 · Options 34 | No | Semler Brossy |
| Sysco Corporation | 115.66% | PSU 50 · RSU 30 · Option 20 | No | Semler Brossy |
| Target Corporation | not disclosed | PSU 60 · PBRSU 40 | No | Semler Brossy |
| The Cigna Group | 100% | PSU 60 · RSU 20 · Options 20 | No | Pay Governance |
| The Kroger Co. | 93.84% | not disclosed | Yes — Value creation (iTSR) | Korn Ferry; Meridian Compensation Partners, LLC |
| Thermo Fisher Scientific Inc. | 99.8% | PSU 50 · Options 50 | Yes — Relative TSR | Pearl Meyer |
| United Parcel Service, Inc. | 75% | PSU 93 · Options 7 | Yes — Relative Total Shareowner Return (RTSR) | FW Cook |
| UnitedHealth Group Incorporated | not disclosed | PSU 50 · Options 25 · RSU 25 | No | Pay Governance |
| Walgreens Boots Alliance, Inc. | not disclosed | RSU 100 | not disclosed | Mercer |
Read from each company’s Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company’s filing does not state the item.
Say-on-pay history and pay ratio
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2025 | 2025-11-05 | 168,382,554 | 17,271,117 | 1,513,298 | 90.7% | Passed |
| 2024 | 2024-11-06 | 172,738,569 | 19,964,307 | 516,807 | 89.64% | Passed |
| 2023 | 2023-11-15 | 182,671,067 | 16,863,757 | 618,935 | 91.55% | Passed |
| 2022 | 2022-11-09 | 184,983,772 | 18,266,030 | 946,572 | 91.01% | Passed |
| 2021 | 2021-11-05 | 194,218,187 | 31,712,173 | 514,906 | 85.77% | Passed |
| 2020 | 2020-11-04 | 142,613,827 | 89,768,639 | 568,367 | 61.22% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.
Say-on-pay — history, company’s computation
| Meeting year | Meeting date | Approval — company’s computation |
|---|---|---|
| 2025 | 2025-11-05 | 90.7%a |
| 2024 | 2024-11-06 | 89.64%b |
| 2023 | 2023-11-15 | 91.55%c |
a. Approved under the standard stated in the filing — “Each of the proposals requires approval by a majority of votes cast.”.
b. Approved under the standard stated in the filing — “Abstentions and broker non-votes are not considered as votes cast and will not be counted in determining the outcome of the voting results.”.
c. Approved under the standard stated in the filing — “Abstentions and broker non-votes are not considered as votes cast and will not be counted in determining the outcome of the voting results.”.
Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
CEO pay ratio
| Ratio (CEO : median employee) | 288 : 1 |
|---|---|
| CEO total compensation | $22,574,349 |
| Median employee compensation | $78,316 |
Insider trades since the proxy
No insider equity transactions reported since the proxy statement.
Sources (63 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Jason Hollar. DEF 14A, filed 2026-09-21. Section “Executive Compensation Tables” · page 58. As printed: 22,574,349. View filing ↗
- Section 01, Aaron Alt. DEF 14A, filed 2026-09-21. Section “Executive Compensation Tables” · page 58. As printed: 6,860,173. View filing ↗
- Section 01, Deborah Weitzman. DEF 14A, filed 2026-09-21. Section “Executive Compensation Tables” · page 58. As printed: 6,120,157. View filing ↗
- Section 01, Jessica Mayer. DEF 14A, filed 2026-09-21. Section “Executive Compensation Tables” · page 58. As printed: 5,534,183. View filing ↗
- Section 01, Stephen Mason. DEF 14A, filed 2026-09-21. Section “Executive Compensation Tables” · page 58. As printed: 5,293,365. View filing ↗
- Section 07, pay ratio. DEF 14A, filed 2026-09-21. Section “CEO Pay Ratio”. As printed: 288 : 1. View filing ↗
- Section 08, Gregory B. Kenny. DEF 14A, filed 2026-09-21. Section “Director Compensation”. As printed: 532,937. View filing ↗
- Section 08, Patricia A. Hemingway Hall. DEF 14A, filed 2026-09-21. Section “Director Compensation”. As printed: 471,844. View filing ↗
- Section 08, Nancy Killefer. DEF 14A, filed 2026-09-21. Section “Director Compensation”. As printed: 376,252. View filing ↗
- Section 08, Sheri H. Edison. DEF 14A, filed 2026-09-21. Section “Director Compensation”. As printed: 376,252. View filing ↗
- Section 08, David C. Evans. DEF 14A, filed 2026-09-21. Section “Director Compensation”. As printed: 366,089. View filing ↗
- Section 08, Akhil Johri. DEF 14A, filed 2026-09-21. Section “Director Compensation”. As printed: 358,277. View filing ↗
- Section 08, Robert W. Musslewhite. DEF 14A, filed 2026-09-21. Section “Director Compensation”. As printed: 353,114. View filing ↗
- Section 08, Robert W. Azelby. DEF 14A, filed 2026-09-21. Section “Director Compensation”. As printed: 353,114. View filing ↗
- Section 08, Sudhakar Ramakrishna. DEF 14A, filed 2026-09-21. Section “Director Compensation”. As printed: 353,114. View filing ↗
- Section 08, Michelle M. Brennan. DEF 14A, filed 2026-09-21. Section “Director Compensation”. As printed: 352,122. View filing ↗
- Section 08, Christine A. Mundkur. DEF 14A, filed 2026-09-21. Section “Director Compensation”. As printed: 333,114. View filing ↗
- Section 08, Jason M. Hollar. DEF 14A, filed 2026-09-21. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 06, 2025 vote. Form 8-K, filed 2025-11-06. Item 5.07 · say-on-pay result. As reported: 90.7% (votes for as printed: 168,382,554). View filing ↗
- Section 06, 2024 vote. Form 8-K, filed 2024-11-07. Item 5.07 · say-on-pay result. As reported: 89.64% (votes for as printed: 172,738,569). View filing ↗
- Section 06, 2023 vote. Form 8-K, filed 2023-11-16. Item 5.07 · say-on-pay result. As reported: 91.55% (votes for as printed: 182,671,067). View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 09b board cost (computed). Computed. Cash 1,542,359 + equity 2,513,870 + all other 170,000 = 4,226,229, summed across the director compensation table rows.
- Thermo Fisher Scientific Inc., Section 10b CEO total. DEF 14A, filed 2026-04-07. CEO total compensation as printed in Thermo Fisher Scientific Inc.'s own proxy. As printed: 79,923,350. View filing ↗
- UnitedHealth Group Incorporated, Section 10b CEO total. DEF 14A, filed 2026-04-21. CEO total compensation as printed in UnitedHealth Group Incorporated's own proxy. As printed: 60,938,062. View filing ↗
- Johnson & Johnson, Section 10b CEO total. DEF 14A, filed 2026-03-11. CEO total compensation as printed in Johnson & Johnson's own proxy. As printed: 32,758,111. View filing ↗
- Baxter International Inc., Section 10b CEO total. DEF 14A, filed 2026-03-23. CEO total compensation as printed in Baxter International Inc.'s own proxy. As printed: 29,805,182. View filing ↗
- FedEx Corporation, Section 10b CEO total. DEF 14A, filed 2026-08-17. CEO total compensation as printed in FedEx Corporation's own proxy. As printed: 27,554,018. View filing ↗
- McKesson Corporation, Section 10b CEO total. DEF 14A, filed 2026-06-12. CEO total compensation as printed in McKesson Corporation's own proxy. As printed: 24,213,044. View filing ↗
- Danaher Corporation, Section 10b CEO total. DEF 14A, filed 2026-03-25. CEO total compensation as printed in Danaher Corporation's own proxy. As printed: 23,795,280. View filing ↗
- Boston Scientific Corporation, Section 10b CEO total. DEF 14A, filed 2026-03-18. CEO total compensation as printed in Boston Scientific Corporation's own proxy. As printed: 23,532,050. View filing ↗
- United Parcel Service, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-19. CEO total compensation as printed in United Parcel Service, Inc.'s own proxy. As printed: 22,878,788. View filing ↗
- The Cigna Group, Section 10b CEO total. DEF 14A, filed 2026-03-13. CEO total compensation as printed in The Cigna Group's own proxy. As printed: 22,866,134. View filing ↗
- Elevance Health, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-27. CEO total compensation as printed in Elevance Health, Inc.'s own proxy. As printed: 22,582,314. View filing ↗
- Cardinal Health (subject), Section 10b CEO total. DEF 14A, filed 2026-09-21. CEO total compensation as printed in Cardinal Health's own proxy. As printed: 22,574,349. View filing ↗
- Stryker Corporation, Section 10b CEO total. DEF 14A, filed 2026-03-23. CEO total compensation as printed in Stryker Corporation's own proxy. As printed: 21,401,495. View filing ↗
- CVS Health Corporation, Section 10b CEO total. DEF 14A, filed 2026-04-03. CEO total compensation as printed in CVS Health Corporation's own proxy. As printed: 21,214,084. View filing ↗
- Labcorp Holdings Inc., Section 10b CEO total. DEF 14A, filed 2026-04-10. CEO total compensation as printed in Labcorp Holdings Inc.'s own proxy. As printed: 18,339,913. View filing ↗
- Cencora, Inc., Section 10b CEO total. DEF 14A, filed 2026-01-22. CEO total compensation as printed in Cencora, Inc.'s own proxy. As printed: 18,256,227. View filing ↗
- Sysco Corporation, Section 10b CEO total. DEF 14A, filed 2026-10-01. CEO total compensation as printed in Sysco Corporation's own proxy. As printed: 17,899,369. View filing ↗
- Becton, Dickinson and Company, Section 10b CEO total. DEF 14A, filed 2025-12-18. CEO total compensation as printed in Becton, Dickinson and Company's own proxy. As printed: 17,129,140. View filing ↗
- The Kroger Co., Section 10b CEO total. DEF 14A, filed 2026-05-13. CEO total compensation as printed in The Kroger Co.'s own proxy. As printed: 14,037,608. View filing ↗
- Walgreens Boots Alliance, Inc., Section 10b CEO total. DEF 14A, filed 2024-12-13. CEO total compensation as printed in Walgreens Boots Alliance, Inc.'s own proxy. As printed: 13,282,800. View filing ↗
- Henry Schein, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-08. CEO total compensation as printed in Henry Schein, Inc.'s own proxy. As printed: 12,013,915. View filing ↗
- Accendra Health, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-02. CEO total compensation as printed in Accendra Health, Inc.'s own proxy. As printed: 11,157,809. View filing ↗
- Target Corporation, Section 10b CEO total. DEF 14A, filed 2026-04-27. CEO total compensation as printed in Target Corporation's own proxy. As printed: 9,598,071. View filing ↗
- Section 10a, Cencora, Inc. reciprocity. DEF 14A. Cencora, Inc. names Cardinal Health in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Walgreens Boots Alliance, Inc. reciprocity. DEF 14A. Walgreens Boots Alliance, Inc.'s most recent proxy was read; its disclosed peer group does not include Cardinal Health. View filing ↗
- Section 10a, United Parcel Service, Inc. reciprocity. DEF 14A. United Parcel Service, Inc.'s most recent proxy was read; its disclosed peer group does not include Cardinal Health. View filing ↗
- Section 10a, Elevance Health, Inc. reciprocity. DEF 14A. Elevance Health, Inc. names Cardinal Health in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Baxter International Inc. reciprocity. DEF 14A. Baxter International Inc.'s most recent proxy was read; its disclosed peer group does not include Cardinal Health. View filing ↗
- Section 10a, The Cigna Group reciprocity. DEF 14A. The Cigna Group names Cardinal Health in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Labcorp Holdings Inc. reciprocity. DEF 14A. Labcorp Holdings Inc.'s most recent proxy was read; its disclosed peer group does not include Cardinal Health. View filing ↗
- Section 10a, UnitedHealth Group Incorporated reciprocity. DEF 14A. UnitedHealth Group Incorporated names Cardinal Health in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Henry Schein, Inc. reciprocity. DEF 14A. Henry Schein, Inc. names Cardinal Health in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Johnson & Johnson reciprocity. DEF 14A. Johnson & Johnson's most recent proxy was read; its disclosed peer group does not include Cardinal Health. View filing ↗
- Section 10a, Target Corporation reciprocity. DEF 14A. Target Corporation's most recent proxy was read; its disclosed peer group does not include Cardinal Health. View filing ↗
- Section 10a, Stryker Corporation reciprocity. DEF 14A. Stryker Corporation's most recent proxy was read; its disclosed peer group does not include Cardinal Health. View filing ↗
- Section 10a, Boston Scientific Corporation reciprocity. DEF 14A. Boston Scientific Corporation's most recent proxy was read; its disclosed peer group does not include Cardinal Health. View filing ↗
- Section 10a, Danaher Corporation reciprocity. DEF 14A. Danaher Corporation's most recent proxy was read; its disclosed peer group does not include Cardinal Health. View filing ↗
- Section 10a, Sysco Corporation reciprocity. DEF 14A. Sysco Corporation's most recent proxy was read; its disclosed peer group does not include Cardinal Health. View filing ↗
- Section 10a, Becton, Dickinson and Company reciprocity. DEF 14A. Becton, Dickinson and Company's most recent proxy was read; its disclosed peer group does not include Cardinal Health. View filing ↗
- Section 10a, Accendra Health, Inc. reciprocity. DEF 14A. Accendra Health, Inc.'s most recent proxy was read; its disclosed peer group does not include Cardinal Health. View filing ↗